|Toll-like receptor 4 is a sensor for autophagy associated with innate immunity|
YI Xu, C Jagannath, XD Liu, A Sharafkhaneh, KE Kolodziejska, NT Eissa
Immunity 27 (1), 135-144, 2007
|Association of psychiatric disorders and sleep apnea in a large cohort|
A Sharafkhaneh, N Giray, P Richardson, T Young, M Hirshkowitz
Sleep 28 (11), 1405-1411, 2005
|A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial|
VS Fan, JM Gaziano, R Lew, J Bourbeau, SG Adams, S Leatherman, ...
Annals of internal medicine 156 (10), 673-683, 2012
|Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort|
NA Hanania, H Müllerova, NW Locantore, J Vestbo, ML Watkins, ...
American journal of respiratory and critical care medicine 183 (5), 604-611, 2011
|Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort|
H Müllerova, DJ Maselli, N Locantore, J Vestbo, JR Hurst, JA Wedzicha, ...
Chest 147 (4), 999-1007, 2015
|Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression|
JA Cully, DP Graham, MA Stanley, CJ Ferguson, A Sharafkhaneh, ...
Psychosomatics 47 (4), 312-319, 2006
|Airway mucus: from production to secretion|
OW Williams, A Sharafkhaneh, V Kim, BF Dickey, CM Evans
American journal of respiratory cell and molecular biology 34 (5), 527-536, 2006
|Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised …|
EFM Wouters, DS Postma, B Fokkens, WCJ Hop, J Prins, AF Kuipers, ...
Thorax 60 (6), 480-487, 2005
|Prevalence, predictors and economic consequences of no-shows|
P Kheirkhah, Q Feng, LM Travis, S Tavakoli-Tabasi, A Sharafkhaneh
BMC health services research 16 (1), 1-6, 2015
|COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial|
ME Kunik, C Veazey, JA Cully, J Souchek, DP Graham, D Hopko, ...
Psychological medicine 38 (3), 385-396, 2008
|Pathogenesis of emphysema: from the bench to the bedside|
A Sharafkhaneh, NA Hanania, V Kim
Proceedings of the American Thoracic Society 5 (4), 475-477, 2008
|Risk indexes for exacerbations and hospitalizations due to COPD|
DE Niewoehner, Y Lokhnygina, K Rice, WG Kuschner, A Sharafkhaneh, ...
Chest 131 (1), 20-28, 2007
|Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology|
JC Hogg, FSF Chu, WC Tan, DD Sin, SA Patel, PD Pare, FJ Martinez, ...
American journal of respiratory and critical care medicine 176 (5), 454-459, 2007
|Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications|
H Qureshi, A Sharafkhaneh, NA Hanania
Therapeutic advances in chronic disease 5 (5), 212-227, 2014
|Oxygen therapy in chronic obstructive pulmonary disease|
V Kim, JO Benditt, RA Wise, A Sharafkhaneh
Proceedings of the American Thoracic Society 5 (4), 513-518, 2008
|Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease|
JH Yun, A Lamb, R Chase, D Singh, MM Parker, A Saferali, J Vestbo, ...
Journal of allergy and clinical immunology 141 (6), 2037-2047. e10, 2018
|Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study|
A Sharafkhaneh, JG Southard, M Goldman, T Uryniak, UJ Martin
Respiratory medicine 106 (2), 257-268, 2012
|A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation|
CCTWGRG Barr, EA Berkowitz, F Bigazzi, F Bode, J Bon, RP Bowler, ...
COPD: Journal of Chronic Obstructive Pulmonary Disease 9 (2), 151-159, 2012
|β-Agonist Intrinsic Efficacy: Measurement and Clinical Significance|
NA Hanania, A Sharafkhaneh, R Barber, BF Dickey
American journal of respiratory and critical care medicine 165 (10), 1353-1358, 2002
|The asthma COPD overlap syndrome (ACOS)|
S Bujarski, AD Parulekar, A Sharafkhaneh, NA Hanania
Current allergy and asthma reports 15, 1-9, 2015